Search Results

You searched for : GLP

	Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in India In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ... May 13
	Sanofi’s diabetes drug Soliqua® now available in India A simple to initiate once-daily solution that breaks through the complexity of living with type 2 diabetes. Nominal therapy cost enables wider access to ... Apr 30
	Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
	Hope for Parkinson’s Patients: Diabetes Drug Lixisenatide Shows Promise in Slowing Disease Progression The potential of repurposing existing medications, such as lixisenatide, to target Parkinson’s disease progression represents a significant stride forward in neurological research.... Apr 05
	Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability Dr. Paul highlighted that the generic sector of pharmaceutical companies currently holds a substantial portion of the Indian pharmaceutical market, exhibiting a growth rate approximately ... Jan 27
	FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ... Nov 17
	Pills or Insulin â€“ Which works best for diabetes management? Of the various factors that contribute to diabetes, a sedentary lifestyle and improper intake of food constitute the major ones. Thus, along with drugs, insulin, ... Jan 04
	BioVaxys enters into a major bioproduction agreement with Wuxi Biologics (Hong Kong) Ltd. ... Mar 16
	Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001 ... Jan 01
	I2O Therapeutics receives strategic investment from Colorcon Ventures Colorcon will collaborate with i2O to accelerate i2Oâ€™s research and development efforts... Dec 04
	Cabinet approves Memorandum of Understanding between India and United Kingdom on cooperation in the field of Medical Products Regulation The MoU will help in establishing a framework for fruitful cooperation and exchange of information between the Central Drugs Standard Control Organization (CDSCO) and the ... Nov 04
	Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million... Oct 29
	GigaGen Initiates large-scale manufacturing of it's COVID-19, drug GIGA-2050 GIGA-2050 is a new class of drug designed to provide passive immunity to COVID-19 patients or those at high risk.... Sep 16
	Brink Biologics announces license agreement with Fresenius Kabi SwissBioSim GmbH Brink Bilogics licenses bioanalytical testing solution to Fresenius Kabi SwissBioSim GmbH... Sep 11
	Potential therapeutics for COVID-19 should be tested for auditory safety The class of drugs used in covid treatment may result in loss of auditory senses... Sep 07
	Best Foods to Control Blood Sugars Studies have proved thatÂ cinnamon can bring down glucose levels and improve insulin affectability, but you should restrict your admission of cinnamon to under 1 ... Sep 03
	Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder Gufic Lifesciences has entered into a loan agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder ... Aug 12
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOMEÂ® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
	Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 ... Sep 13
	Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA Aptorum Group Limited (Nasdaq: APM) (â€œAptorum Groupâ€), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that ... Sep 12
20 Matching result(s) found!

-Advertisements-

Trending Now
	Moscow Outpatient Departments to Implement AI X-ray InterpretationMay 31, 2024
	FLO launched Digital Ready Reckoner - of MSME schemes.May 31, 2024
	Candy flavoured traps to hook the next generationMay 31, 2024
	Software Engineering Research Centre (SERC) at IIIT H to host 21st Edition of IEEE International Conference on Software Architecture (ICSA) 2024May 31, 2024
	Federal Bank and Tata AIA Life Insurance Announce Strategic Bancassurance PartnershipMay 31, 2024
	Why Whole Spices are Better than Powdered: New ICMR GuidelinesMay 31, 2024
	Raising Awareness on Menstrual Health: NCW and SheWings Initiative on Menstrual Hygiene DayMay 31, 2024
	Innovative RNA Drugs Offer Hope for Patients with High CholesterolMay 31, 2024
	Advani Hotels & Resorts (India) Limited (Caravela Beach Resort, Goa)May 30, 2024
	FLO Hyderabad launches ‘Centre of Excellence for Training Women Vegetable Farming’May 30, 2024
	Should Doctors Be Exempt from the Consumer Protection Act? A Complex DebateMay 30, 2024
	Tamil Nadu Doctors Save 14-Year-Old Girl by Removing Needle from Lung with BronchoscopyMay 30, 2024
	The Lifesaving Journey of a Florist: Rare 'Bombay' Blood Group Donation Saves Life May 30, 2024
	The Impact of Heat on Eye Health: Preventing Eye Strokes During High TemperaturesMay 30, 2024
	Patients with super morbid obesity can find life-changing benefits beyond weight reduction through bariatric surgeryMay 29, 2024
	AI software could revolutionise voice box cancer treatmentMay 29, 2024
	Why You’re Waking Up to Pee: The Link Between Enlarged Prostate and NocturiaMay 29, 2024
	Rising Smoking Rates Among Teenage Girls: A Growing Health Crisis in IndiaMay 29, 2024
	WHO Launches $7 Billion Investment Round at the 77th World Health AssemblyMay 29, 2024
	From Insulin-Dependent to Insulin-Free in just 3 months: Game-Changing Diabetes Cure Developed by Chinese ScientistsMay 29, 2024

Search Results

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in India

Sanofi’s diabetes drug Soliqua® now available in India

Biocon Ventures into Weight-Loss Drug Market with Semaglutide Development

Hope for Parkinson’s Patients: Diabetes Drug Lixisenatide Shows Promise in Slowing Disease Progression

Empowering India's Healthcare: Dr. Sujit Paul Unveils Davaindia's Commitment to Quality and Affordability

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

Pills or Insulin â€“ Which works best for diabetes management?

BioVaxys enters into a major bioproduction agreement with Wuxi Biologics (Hong Kong) Ltd.

Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment

I2O Therapeutics receives strategic investment from Colorcon Ventures

Cabinet approves Memorandum of Understanding between India and United Kingdom on cooperation in the field of Medical Products Regulation

Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million

GigaGen Initiates large-scale manufacturing of it's COVID-19, drug GIGA-2050

Brink Biologics announces license agreement with Fresenius Kabi SwissBioSim GmbH

Potential therapeutics for COVID-19 should be tested for auditory safety

Best Foods to Control Blood Sugars

Gufic Lifesciences signs contract with Hetero Labs for Remdesivir lyophilised powder

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA

Trending Now